VM
VHCP Management Portfolio holdings
AUM
$93M
This Quarter Return
+20.1%
1 Year Return
-10.46%
3 Year Return
+232.85%
5 Year Return
–
10 Year Return
–
AUM
$390M
AUM Growth
+$390M
(+10%)
Cap. Flow
-$23.5M
Cap. Flow
% of AUM
-6.03%
Top 10 Holdings %
Top 10 Hldgs %
86.28%
Holding
21
New
3
Increased
–
Reduced
1
Closed
3
Top Buys
1 |
Regenxbio
RGNX
|
$20.2M |
2 |
AKTX
Akari Therapeutics
AKTX
|
$12.7M |
3 |
SRRA
Sierra Oncology, Inc. Common Stock
SRRA
|
$5.13M |
Top Sells
1 |
ORKA
Oruka Therapeutics, Inc. Common Stock
ORKA
|
$45.9M |
2 |
BioCryst Pharmaceuticals
BCRX
|
$5.58M |
3 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
$5.24M |
4 |
JUNO
Juno Therapeutics, Inc.
JUNO
|
$4.81M |
Sector Composition
1 | Healthcare | 50.65% |